Please wait while the formulary information is being retrieved.
ANNOVERA (segesterone acetate/ethinyl estradiol)
- birth control
0.15 mg-0.013 mg/24 hr vaginal ring
- Insert 1 vaginal ring by vaginal route once a month leave in place for 3 weeks, remove for 1 week
Default screening record
- Insert 1 vaginal ring by vaginal route once a month leave in place for 3 weeks, remove for 1 week
- anastrozole
- Arimidex
- Aromasin
- Cyklokapron
- exemestane
- Femara
- letrozole
- Lysteda
- sodium tetradecyl sulfate
- Sotradecol
- tranexamic acid
Contraindicated
- Alagesic Lq
- amobarbital
- Amytal
- Aptiom
- Aptivus
- artemether-lumefantrine
- Ascomp With Codeine
- atazanavir
- Atripla
- B cplx-C-St.Johnwrt-K.&S.ginsg
- Banzel
- Belladonna-phenobarbital
- boceprevir
- bosentan
- Brevital
- Bupap
- butabarbital
- Butalbital Compound W/codeine
- Butalbital Compound-codeine
- butalbital-acetaminop-caf-cod
- butalbital-acetaminophen
- butalbital-acetaminophen-caff
- butalbital-aspirin-caffeine
- Butisol
- calcium-mag-B complex-D3-hrb61
- Capacet
- carbamazepine
- Carbatrol
- Cellcept
- Cellcept Intravenous
- Cerebyx
- chloramphenicol sod succinate
- clobazam
- Coartem
- codeine-butalbital-ASA-caff
- Cold & Flu Fighter
- dabrafenib
- darunavir
- Dilantin
- Dilantin Extended
- Dilantin Infatabs
- Dilantin Kapseal
- Dilantin-125
- Donnatal
- efavirenz
- efavirenz-emtricitabin-tenofov
- elvitegr-cobicist-emtric-tenof
- Epitol
- Equetro
- Esgic
- eslicarbazepine
- ethotoin
- Fatigue Relief Complex
- felbamate
- Felbatol
- Fioricet
- Fioricet With Codeine
- Fiorinal
- Fiorinal-codeine #3
- fosamprenavir
- fosphenytoin
- Fycompa
- Grifulvin V
- Gris-peg (ultramicrosize)
- griseofulvin microsize
- griseofulvin ultramicrosize
- Incivek
- Invirase
- isoniazid-rifamp-pyrazinamide
- Kaletra
- Korlym
- Lexiva
- lopinavir-ritonavir
- Luminal
- Margesic
- Marten-tab
- methohexital
- mifepristone
- modafinil
- Mycobutin
- mycophenolate mofetil
- mycophenolate mofetil HCl
- mycophenolate sodium
- Myfortic
- Mysoline
- nelfinavir
- Nembutal Sodium
- nevirapine
- Norvir
- Norvir Soft Gelatin
- Onfi
- oxcarbazepine
- Oxtellar Xr
- Peganone
- pentobarbital sodium
- perampanel
- phenobarb-hyoscy-atropine-scop
- phenobarbital
- phenobarbital sodium
- phentermine-topiramate
- Phenytek
- phenytoin
- phenytoin sodium
- phenytoin sodium extended
- Prezista
- Priftin
- primidone
- Provigil
- Qsymia
- Reyataz
- rifabutin
- Rifadin
- Rifamate
- rifampin
- rifampin-isoniazid
- rifapentine
- Rifater
- ritonavir
- rufinamide
- saquinavir mesylate
- secobarbital sodium
- Seconal Sodium
- St. John's wort
- Stribild
- Sustiva
- Tafinlar
- Tegretol
- Tegretol Xr
- telaprevir
- Tencon
- tipranavir
- tizanidine
- Topamax
- Topiragen
- topiramate
- Tracleer
- Trileptal
- Trokendi Xr
- Victrelis
- Viracept
- Viramune
- Viramune Xr
- vit C-St. John wort-elder-hb30
- Women's Complex
- Zanaflex
- Zebutal
Severe
Moderate
- A-hydrocort
- A-methapred
- aminophylline
- Anucort-hc
- Anusol-hc
- aprepitant
- Aristospan Intra-articular
- Aristospan Intralesional
- Azilect
- betamethasone acet & sod phos
- Bivigam
- budesonide
- Carimune Nf Nanofiltered
- Celestone Soluspan
- Colocort
- Cortef
- Cortenema
- Cortifoam
- cortisone
- Depo-medrol
- dexamethasone
- Dexamethasone Intensol
- dexamethasone sodium phos (PF)
- dexamethasone sodium phosphate
- Dexpak 10 Day
- Dexpak 13 Day
- Dexpak 6 Day
- Elixophyllin
- Emend
- Entocort Ec
- Ez Use Joint-tunnel-trigger
- First-duke's
- First-mary's Mouthwash
- Flebogamma Dif
- Flo-pred
- fludrocortisone
- fosaprepitant
- Gamastan S/d
- Gammagard Liquid
- Gammagard S-d (iga < 1 Mcg/ml)
- Gammagard S/d
- Gammaked
- Gammaplex
- Gamunex-c
- Grx Hicort 25
- Hemril-30
- Hizentra
- hydrocortisone
- hydrocortisone acetate
- hydrocortisone sod succ (PF)
- hydrocortisone sod succinate
- immune glob(IgG)(hum)-maltose
- immune globulin (human) (IgG)
- immune globulin(hum),capr(IgG)
- Kenalog
- Lamictal
- Lamictal Odt
- Lamictal Odt Starter (blue)
- Lamictal Odt Starter (green)
- Lamictal Odt Starter (orange)
- Lamictal Starter (blue) Kit
- Lamictal Starter (green) Kit
- Lamictal Starter (orange) Kit
- Lamictal Xr
- Lamictal Xr Starter (blue)
- Lamictal Xr Starter (green)
- Lamictal Xr Starter (orange)
- lamotrigine
- Medrol
- Medrol (pak)
- methylprednisolone
- methylprednisolone acetate
- methylprednisolone sod suc(PF)
- methylprednisolone sodium succ
- methylprednisolone-bupivacaine
- Millipred
- Millipred Dp
- nystatin-hydrocortisone-diphen
- nystatin-TCN-HC-diphenhydramin
- Octagam
- Orapred
- Orapred Odt
- Pediapred
- Physicians Ez Use M-pred
- prednisolone
- prednisolone acetate
- prednisolone sodium phosphate
- prednisone
- Prednisone Intensol
- Privigen
- Proctocort
- rasagiline
- Rayos
- Rectacort-hc
- Solu-cortef
- Solu-cortef (pf)
- Solu-medrol
- Solu-medrol (pf)
- Theo-24
- Theochron
- theophylline
- theophylline in dextrose 5 %
- triamcinolone acetonide
- triamcinolone hexacetonide
- triamcinolone-lidocaine
- Uceris
- Veripred 20
- Acute myocardial infarction
- Antithrombin III deficiency
- Carcinoma of breast
- Cerebrovascular accident
- Deep venous thrombosis
- Endometrial carcinoma
- Estrogen-dependent neoplasm
- History of deep vein thrombosis
- History of pulmonary embolism
- Neoplasm of liver
- Porphyria
- Predisposition to thrombosis
- Protein C deficiency disease
- Pulmonary thromboembolism
- Severe hepatic disease
- Thromboembolic disorder
- Thrombophilia
Contraindicated
- Acute myocardial infarction
- Bed-ridden
- Cerebrovascular accident
- Coronary artery disease
- Deep venous thrombosis
- Dementia
- Disease of liver
- Family history of malignant tumor of breast
- Hereditary angioedema
- Hypercalcemia
- Invasive surgical procedure
- Malignant neoplasm of the ovary
- Migraine
- Obesity
- Papilledema
- Predisposition to thrombosis
- Pulmonary thromboembolism
- Retinal thrombosis
- Thromboembolic disorder
- Thrombophlebitis
- Tobacco smoker
Severe
Moderate
- Asthma
- Depression
- Diabetes mellitus
- Edema
- Gallbladder disease
- Hepatic porphyria
- Hyperlipidemia
- Hypertension
- Hypertriglyceridemia
- Hypoparathyroidism
- Hypothyroidism
- Migraine
- Seizure disorder
- Systemic lupus erythematosus
- Unspecified lump in breast
- Uterine leiomyoma
ANNOVERA (segesterone acetate/ethinyl estradiol)
- birth control
- None
- Abnormal vaginal bleeding
- Acute abdominal pain
- Depression
- Diarrhea
- Genital organ pruritus
- Headache disorder
- Mood changes
- Nausea
- Vaginitis
More Frequent
Severe
Less Severe
- None
- Acne vulgaris
- Dysmenorrhea
- Libido changes
- Mastalgia
- Migraine
- Vaginal discharge
- Vomiting
- Weight gain
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Acute arterial thromboembolism
- Acute myocardial infarction
- Anaphylaxis
- Angioedema
- Benign hepatic cell adenoma
- Biliary calculus
- Cerebral thrombosis
- Cerebrovascular accident
- Colitis
- Gallbladder disease
- Hearing loss
- Hemorrhagic stroke
- Hypertension
- Liver cell carcinoma
- Pulmonary thromboembolism
- Retinal thrombosis
- Systemic lupus erythematosus
- Thromboembolic disorder
- Thrombophlebitis
- Toxic shock syndrome
- Venous thrombosis
Less Severe
- Amenorrhea
- Chloasma
- Endocervical lesions
- Galactorrhea not associated with childbirth
- Hypertriglyceridemia
- Irregular menstrual periods
- Menorrhagia
- Obstructive hyperbilirubinemia
- Skin rash
- Symptoms of anxiety
- Urticaria
- Vaginal irritation
Contraindicated
None
Severe Precaution
Vaginal Contraceptives
Not indicated before menarche.
- 1 Day – 12 Years
- Not indicated before menarche.
Management or Monitoring Precaution
None
Ethinyl Estradiol-segesterone
- Severity Level:
2
- Additional Notes: Available human data show no increased risk for major birth defects.
Contraindicated
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Precaution Exists
Ethinyl Estrasdiol-segersterone
None
General | Excretion Potential | Effect on Infant | Notes |
Evaluate use carefully | Excreted | Not known; no or inclusive data | None |
No Known Risk
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- Do not use this medication if you smoke cigarettes/use tobacco and are over 35 years old. Smoking raises your risk of stroke, heart attack, blood clots, and high blood pressure from hormonal birth control (such as the pill, patch, ring). The risk of these serious problems increases with age and with the number of cigarettes you smoke. Do not smoke or use tobacco.
Pregnancy contraception | |
Z30 | Encounter for contraceptive management |
Z30.01 | Encounter for initial prescription of contraceptives |
Z30.011 | Encounter for initial prescription of contraceptive pills |
Z30.013 | Encounter for initial prescription of injectable contraceptive |
Z30.014 | Encounter for initial prescription of intrauterine contraceptive device |
Z30.015 | Encounter for initial prescription of vaginal ring hormonal contraceptive |
Z30.016 | Encounter for initial prescription of transdermal patch hormonal contraceptive device |
Z30.017 | Encounter for initial prescription of implantable subdermal contraceptive |
Z30.018 | Encounter for initial prescription of other contraceptives |
Z30.019 | Encounter for initial prescription of contraceptives, unspecified |
Z30.4 | Encounter for surveillance of contraceptives |
Z30.40 | Encounter for surveillance of contraceptives, unspecified |
Z30.41 | Encounter for surveillance of contraceptive pills |
Z30.42 | Encounter for surveillance of injectable contraceptive |
Z30.43 | Encounter for surveillance of intrauterine contraceptive device |
Z30.430 | Encounter for insertion of intrauterine contraceptive device |
Z30.431 | Encounter for routine checking of intrauterine contraceptive device |
Z30.433 | Encounter for removal and reinsertion of intrauterine contraceptive device |
Z30.44 | Encounter for surveillance of vaginal ring hormonal contraceptive device |
Z30.45 | Encounter for surveillance of transdermal patch hormonal contraceptive device |
Z30.46 | Encounter for surveillance of implantable subdermal contraceptive |
Z30.49 | Encounter for surveillance of other contraceptives |
Z30.8 | Encounter for other contraceptive management |
Z30.9 | Encounter for contraceptive management, unspecified |
Z79.3 | Long term (current) use of hormonal contraceptives |
Z97.5 | Presence of (intrauterine) contraceptive device |
0-9 | A-Z |
---|---|
Z30 | Encounter for contraceptive management |
Z30.01 | Encounter for initial prescription of contraceptives |
Z30.011 | Encounter for initial prescription of contraceptive pills |
Z30.013 | Encounter for initial prescription of injectable contraceptive |
Z30.014 | Encounter for initial prescription of intrauterine contraceptive device |
Z30.015 | Encounter for initial prescription of vaginal ring hormonal contraceptive |
Z30.016 | Encounter for initial prescription of transdermal patch hormonal contraceptive device |
Z30.017 | Encounter for initial prescription of implantable subdermal contraceptive |
Z30.018 | Encounter for initial prescription of other contraceptives |
Z30.019 | Encounter for initial prescription of contraceptives, unspecified |
Z30.4 | Encounter for surveillance of contraceptives |
Z30.40 | Encounter for surveillance of contraceptives, unspecified |
Z30.41 | Encounter for surveillance of contraceptive pills |
Z30.42 | Encounter for surveillance of injectable contraceptive |
Z30.43 | Encounter for surveillance of intrauterine contraceptive device |
Z30.430 | Encounter for insertion of intrauterine contraceptive device |
Z30.431 | Encounter for routine checking of intrauterine contraceptive device |
Z30.433 | Encounter for removal and reinsertion of intrauterine contraceptive device |
Z30.44 | Encounter for surveillance of vaginal ring hormonal contraceptive device |
Z30.45 | Encounter for surveillance of transdermal patch hormonal contraceptive device |
Z30.46 | Encounter for surveillance of implantable subdermal contraceptive |
Z30.49 | Encounter for surveillance of other contraceptives |
Z30.8 | Encounter for other contraceptive management |
Z30.9 | Encounter for contraceptive management, unspecified |
Z79.3 | Long term (current) use of hormonal contraceptives |
Z97.5 | Presence of (intrauterine) contraceptive device |
Formulary Reference Tool